Moore Capital Management, LP Catalent, Inc. Transaction History
Moore Capital Management, LP
- $4.85 Billion
- Q3 2024
A detailed history of Moore Capital Management, LP transactions in Catalent, Inc. stock. As of the latest transaction made, Moore Capital Management, LP holds 62,000 shares of CTLT stock, worth $3.65 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
62,000
Previous 70,000
11.43%
Holding current value
$3.65 Million
Previous $3.94 Million
4.6%
% of portfolio
0.08%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding CTLT
# of Institutions
510Shares Held
150MCall Options Held
510KPut Options Held
2M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$905 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$439 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$377 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$266 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.6B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...